Method of treating premature uterine contractions using the opti

Details Method of treating premature uterine contractions using the opti Method of treating premature uterine contractions using the opti

1996-01-29

1998-01-13

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

514649, 514935, A61K 31135

Patent

active

057080364

ABSTRACT:
The optically pure R-isomer of the adrenergic beta-2 agonist albuterol, substantially free of its corresponding S-isomer, has been found to potently inhibit premature uterine contractions in female subjects, suffering from said condition, while avoiding side effects associated with the corresponding S-isomer. A new method is disclosed utilizing the optically pure R(-)-isomer of albuterol for treating premature uterine contractions while minimizing the side effects associated with administration of racemic albuterol.

REFERENCES:
patent: 5164189 (1992-11-01), Faradieh et al.
patent: 5290561 (1994-03-01), Faradieh et al.
patent: 5362755 (1994-11-01), Barberich et al.

Affiliated with

Also associated with

Rating

Method of treating premature uterine contractions using the opti does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating premature uterine contractions using the opti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating premature uterine contractions using the opti will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-326813